Join the club for FREE to access the whole archive and other member benefits.

Mikhail Blagosklonny

Professor of oncology at the Roswell Park Cancer Institute

Mikhail (Misha) V. Blagosklonny graduated with an MD and PhD from First Pavlov State Medical University of St. Petersburg, Russia. Dr. Mikhail V. Blagosklonny subsequently relocated to the United States, where he was awarded the prestigious Fogarty Fellowship from the National Institutes of Health. During his fellowship in Leonard Neckers’ laboratory at the National Cancer Institute (NCI), he was a co-author of 18 publications on diverse biomedical topics, including targeting HSP90, p53, Bcl2, Erb2, and Raf-1. He also was the last author on a clinical phase I/II trial paper.

Visit website: https://www.roswellpark.org/mikhail-blagosklonny

 Login to view link, or join the club to get full access to all resources and other benefits.

See also: Institute Roswell Park Comprehensive Cancer Center - First center in USA focused on cancer research and treatment

Mikhail Blagosklonny is also referenced in the following:

Event

Workshop is part of ARDD 2021 conference that brings health care providers involved in longevity, organized by Cassandra Coburn and Evelyne Bischof. (FREE)

Mikhail Blagosklonny News

DNA-damage or telomere shortening may not cause normal ageing

EurekAlert! - 08-Jun-2021

Rapamycin fails to extend lifespan in telomerase-deficient mice, while improving lifespan by 39% in normal mice

Read more...

Rapamycin shows a sixty percent life expectancy increase in mice model

Aging - 04-Oct-2019

Detailed history and review of current understanding of Rapamycin and longevity

Read more...

Everyday drugs could give extra years of life

New Scientist - 01-Oct-2014

Rapamycin in mice The study was published in the Diabetes, Obesity and Metabolism journal.

Read more...